Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial

Matthew W Semler, Wesley H Self, Li Wang, Daniel W Byrne, Jonathan P Wanderer, Jesse M Ehrenfeld, Joanna L Stollings, Avinash B Kumar, Antonio Hernandez, Oscar D Guillamondegui, Addison K May, Edward D Siew, Andrew D Shaw, Gordon R Bernard, Todd W Rice, Isotonic Solutions and Major Adverse Renal Events Trial (SMART) Investigators, Pragmatic Critical Care Research Group, Gordon R Bernard, Jonathan D Casey, Matthew W Semler, Michael J Noto, Todd W Rice, Daniel W Byrne, Henry J Domenico, Li Wang, Jesse M Ehrenfeld, Jonathan P Wanderer, Andrew D Shaw, Antonio Hernandez, Avinash B Kumar, Christopher G Hughes, Emily Holcombe, Jayme Gibson, Lisa Weavind, Mias Pretorius, William T Costello, Wesley H Self, Edward D Siew, Debra F Dunlap, Joanna L Stollings, Kelli A Rumbaugh, Leanne Atchison, Mark Sullivan, Matthew Felbinger, Molly Knostman, Susan E Hamblin, Addison K May, Jason B Young, Julie Y Valenzuela, Oscar D Guillamondegui, David P Mulherin, Fred R Hargrove, Seth Strawbridge, Matthew W Semler, Wesley H Self, Li Wang, Daniel W Byrne, Jonathan P Wanderer, Jesse M Ehrenfeld, Joanna L Stollings, Avinash B Kumar, Antonio Hernandez, Oscar D Guillamondegui, Addison K May, Edward D Siew, Andrew D Shaw, Gordon R Bernard, Todd W Rice, Isotonic Solutions and Major Adverse Renal Events Trial (SMART) Investigators, Pragmatic Critical Care Research Group, Gordon R Bernard, Jonathan D Casey, Matthew W Semler, Michael J Noto, Todd W Rice, Daniel W Byrne, Henry J Domenico, Li Wang, Jesse M Ehrenfeld, Jonathan P Wanderer, Andrew D Shaw, Antonio Hernandez, Avinash B Kumar, Christopher G Hughes, Emily Holcombe, Jayme Gibson, Lisa Weavind, Mias Pretorius, William T Costello, Wesley H Self, Edward D Siew, Debra F Dunlap, Joanna L Stollings, Kelli A Rumbaugh, Leanne Atchison, Mark Sullivan, Matthew Felbinger, Molly Knostman, Susan E Hamblin, Addison K May, Jason B Young, Julie Y Valenzuela, Oscar D Guillamondegui, David P Mulherin, Fred R Hargrove, Seth Strawbridge

Abstract

Background: Saline, the intravenous fluid most commonly administered to critically ill adults, contains a high chloride content, which may be associated with acute kidney injury and death. Whether using balanced crystalloids rather than saline decreases the risk of acute kidney injury and death among critically ill adults remains unknown.

Methods: The Isotonic Solutions and Major Adverse Renal Events Trial (SMART) is a pragmatic, cluster-level allocation, cluster-level crossover trial being conducted between 1 June 2015 and 30 April 2017 in five intensive care units at Vanderbilt University Medical Center in Nashville, TN, USA. SMART compares saline (0.9% sodium chloride) with balanced crystalloids (clinician's choice of lactated Ringer's solution or Plasma-Lyte A®). Each intensive care unit is assigned to provide either saline or balanced crystalloids each month, with the assigned crystalloid alternating monthly over the course of the trial. All adults admitted to participating intensive care units during the study period are enrolled and followed until hospital discharge or 30 days after enrollment. The anticipated enrollment is approximately 14,000 patients. The primary outcome is Major Adverse Kidney Events within 30 days-the composite of in-hospital death, receipt of new renal replacement therapy, or persistent renal dysfunction (discharge creatinine ≥200% of baseline creatinine). Secondary clinical outcomes include in-hospital mortality, intensive care unit-free days, ventilator-free days, vasopressor-free days, and renal replacement therapy-free days. Secondary renal outcomes include new renal replacement therapy receipt, persistent renal dysfunction, and incidence of stage 2 or higher acute kidney injury.

Discussion: This ongoing pragmatic trial will provide the largest and most comprehensive comparison to date of clinical outcomes with saline versus balanced crystalloids among critically ill adults.

Trial registration: For logistical reasons, SMART was prospectively registered separately for the medical ICU (SMART-MED; ClinicalTrials.gov identifier: NCT02444988 ; registered on 11 May 2015; date of first patient enrollment: 1 June 2015) and the nonmedical ICUs (SMART-SURG; ClinicalTrials.gov identifier: NCT02547779 ; registered on 9 September 2015; date of first patient enrollment: 1 October 2015).

Keywords: Crystalloid; Intravenous fluids; Pragmatic trial; Renal failure; Saline.

Figures

Fig. 1
Fig. 1
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist. Enrollment, interventions, and assessments. ICU Intensive care unit
Fig. 2
Fig. 2
Crystalloid assignment during the trial. During each month of the study, each intensive care unit is assigned to use either 0.9% saline (S) or balanced crystalloids (B)
Fig. 3
Fig. 3
Flow diagram of progress of patients through the trial. ICU Intensive care unit

References

    1. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185. doi: 10.1186/cc9293.
    1. Yunos NM, Kim IB, Bellomo R, Bailey M, Ho L, Story D, et al. The biochemical effects of restricting chloride-rich fluids in intensive care. Crit Care Med. 2011;39:2419–24. doi: 10.1097/CCM.0b013e31822571e5.
    1. Smith RJ, Reid DA, Delaney EF, Santamaria JD. Fluid therapy using a balanced crystalloid solution and acid–base stability after cardiac surgery. Crit Care Resusc. 2010;12:235–41.
    1. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726–35. doi: 10.1172/JCI110820.
    1. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-Lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18–24. doi: 10.1097/SLA.0b013e318256be72.
    1. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566–72. doi: 10.1001/jama.2012.13356.
    1. Raghunathan K, Shaw A, Nathanson B, Stürmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med. 2014;42:1585–91. doi: 10.1097/CCM.0000000000000305.
    1. Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med. 2014;161:347–55. doi: 10.7326/M14-0178.
    1. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897–905. doi: 10.1007/s00134-014-3505-3.
    1. Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012;255:821–9. doi: 10.1097/SLA.0b013e31825074f5.
    1. Sen A, Keener CM, Sileanu FE, Foldes E, Clermont G, Murugan R, et al. Chloride content of fluids used for large-volume resuscitation is associated with reduced survival. Crit Care Med. 2017;45:e146–53. doi: 10.1097/CCM.0000000000002063.
    1. Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015;102:24–36. doi: 10.1002/bjs.9651.
    1. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314:1701–10. doi: 10.1001/jama.2015.12334.
    1. Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, et al. Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial. Am J Respir Crit Care Med. doi:10.1164/rccm.201607-1345OC.
    1. Young P. Saline is the solution for crystalloid resuscitation. Crit Care Med. 2016;44:1538–40. doi: 10.1097/CCM.0000000000001844.
    1. Semler MW, Rice TW. Saline is not the first choice for crystalloid resuscitation fluids. Crit Care Med. 2016;44:1541–4. doi: 10.1097/CCM.0000000000001941.
    1. Dellinger RP. Crystalloids for fluid resuscitation in sepsis: where is the balance? Ann Intern Med. 2014;161:372–3. doi: 10.7326/M14-1565.
    1. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. doi: 10.1136/bmj.e7586.
    1. Ware JH, Hamel MB. Pragmatic trials—guides to better patient care? N Engl J Med. 2011;364:1685–7. doi: 10.1056/NEJMp1103502.
    1. Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA. 2015;313:369–78. doi: 10.1001/jama.2014.18400.
    1. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243–51. doi: 10.1056/NEJMra1208627.
    1. Lorenzo M, Davis JW, Negin S, Kaups K, Parks S, Brubaker D, et al. Can Ringer’s lactate be used safely with blood transfusions? Am J Surg. 1998;175:308–10. doi: 10.1016/S0002-9610(98)00011-7.
    1. Semler MW, Rice TW, Shaw AD, Siew ED, Self WH, Kumar AB, et al. Identification of major adverse kidney events within the electronic health record. J Med Syst. 2016;40:167. doi: 10.1007/s10916-016-0528-z.
    1. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012;7:844–50. doi: 10.2215/CJN.12791211.
    1. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25. doi: 10.1186/cc12503.
    1. Závada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, et al. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010;25:3911–8. doi: 10.1093/ndt/gfp766.
    1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2 Suppl:1–138.
    1. Parienti JJ, Kuss O. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies. Contemp Clin Trials. 2007;28:316–23. doi: 10.1016/j.cct.2006.10.004.
    1. Turner RM, White IR, Croudace T, PIP Study Group Analysis of cluster randomized cross-over trial data: a comparison of methods. Stat Med. 2007;26:274–89. doi: 10.1002/sim.2537.
    1. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901–11. doi: 10.1056/NEJMoa1209759.
    1. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56. doi: 10.1056/NEJMoa040232.
    1. Weisbord SD, Gallagher M, Kaufman J, Cass A, Parikh CR, Chertow GM, et al. Prevention of contrast-induced AKI: a review of published trials and the design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) trial. Clin J Am Soc Nephrol. 2013;8:1618–31. doi: 10.2215/CJN.11161012.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa